Active Not Recruiting OBSERVATIONAL NCT07163000
Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT) (ACT)
Sponsor: Hamad Medical Corporation
Conditions
Diabetes (DM) Painful Neuropathy Peripheral Neuropathy
Updated 1 time since 2025 Last updated: Aug 31, 2025 Started: May 11, 2025 Primary completion: Dec 30, 2026 Completion: Dec 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07163000, this observational or N/A phase trial focuses on Diabetes (DM) and Painful Neuropathy and remains ongoing. Sponsored by Hamad Medical Corporation, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Active Not Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Hamad Medical Corporation
- Procter and Gamble
- Weill Cornell Medical College in Qatar
Data source: Weill Cornell Medical College in Qatar
For direct contact, visit the study record on ClinicalTrials.gov .